Schering Peginterferon European Indication Restricted To Rebetron Failures
Executive Summary
Schering-Plough's peginterferon alfa-2b should be used as monotherapy in hepatitis C patients who have failed or are intolerant to ribavirin in interferon-alfa/ribavirin combination therapy (Rebetron), the European Committee for Proprietary Medicinal Products recommends.